Abstract
The influence of different surface modifications with poly(ethyleneglycol) (PEG) layers on the adsorption of fibrinogen and the adhesion and activation of macrophage-like human leukocytes was investigated. Poly(ethylene terephthalate) (PET) was modified using pulsed AC plasma polymerization with two types of starting monomers to generate: 1) a reactive acid surface using maleic anhydride (MAH) as monomer, and 2) a PEG-like surface using diethyleneglycol methyl vinyl ether (DEGVE) as monomer. The MAH surface was used as a reactive platform to graft linear chains of non-fouling mPEG via an intermediate layer of poly(ethyleneimine) (PEI) under lower critical solution temperature (LCST) conditions of the mPEG. The DEGVE monomer is used to create PEG-like layers by use of low power plasma conditions. The ability of the surfaces to resist protein adsorption was investigated quantitatively using 125I-radiolabeled human fibrinogen, and the conformation of the adsorbed protein was tested using an anti-fibrinogen monoclonal antibody in an enzyme-linked immunosorbent assay. The results showed that PEGylated surfaces adsorbed significantly less (up to 90% less) fibrinogen, and that unfolding of adsorbed fibrinogen was more pronounced on the linear mPEG layers than on the PEG-like plasma polymer surfaces. Adhesion of in-vitro differentiated macrophage-like U937 cells was reduced on both the PEG-like plasma polymer surfaces and the linear mPEG layers compared to the unmodified PET surface, but cells adhering to the PEG-like plasma polymer surfaces secreted less tumor necrosis factor-α (TNF- α) than cells adhering to the linear mPEG layers. In conclusion, the method for preparing non-fouling surfaces for long-term implanted devices influence surface-induced cellular responses of the host.
Similar content being viewed by others
References
N. F. HASSAN, N. KAMANI, M. M. MESZAROS and S. D. DOUGLAS, J. Immunol. 143 (1989) 2179.
J. M. ANDERSON, ASAIO Trains. 11 (1988) 101.
P. THOMSEN and C. GRETZER, Curr. Opin. Solid State Mater. Sci. 5 (2001) 163.
M. SHEN and T. A. HORBETT, J. Biomed. Mater. Res. 57 (2001) 336.
G. BERTON and C. A. LOWELL, Cell Signal. 11 (1999) 621.
N. P. ZIATS, K. M. MILLER and J. M. ANDERSON, Biomaterials 9 (1988) 5.
K. M. MILLER and J. M. ANDERSON, J. Biomed. Mater. Res. 22 (1988) 713.
D. Y. UNG, K. A. WOODHOUSE and M. V. SEFTON, J. Biomed. Mater. Res. 46 (1999) 324.
C. JENNEY and J. ANDERSON, J. Biomed. Mater. Res. 49 (2000) 435.
A. ROSENGREN, L. M. BJURSTEN, N. DANIELSEN, H. PERSSON and M. KOBER, J. Mater. Sci.: Mater. Med. 10 (1999) 75.
W. G. BRODBECK, M. S. SHIVE, E. COLTON, Y. NAKAYAMA, T. MATSUDA and J. M. ANDERSON, J. Biomed. Mater. Res. 55 (2001) 661.
W. G. BRODBECK, G. VOSKERICIAN, N. P. ZIATS, Y. NAKAYAMA, T. MATSUDA and J. M. ANDERSON, J. Biomed. Mater. Res. 64 (2003) 320.
W. G. BRODBECK, Y. NAKAYAMA, T. MATSUDA, E. COLTON, N. P. ZIATS and J. M. ANDERSON, Cytokine 18(2002) 311.
J. H. LEE, H. B. LEE and J. D. ANDRADE, Prog. Polym. Sci. 20 (1995) 1043.
S. I. JEON, J. H. LEE, J. D. ANDRADE and P. G. DEGANNES, J. Colloid and Interface Sci. 142 (1991) 149.
I. SZLEIFER, Physica A 1 (1997) 370.
W. J. KAO and J. A. HUBBELL, Biotechnol. Bioengr. 59 (1998) 2.
C. R. JENNEY and J. M. ANDERSON, J. Biomed. Mater. Res. 44 (1999) 206.
M. C. SHEN, Y. V. PAN, M. S. WAGNER, K. D: HAUCH, D. G. CASTNER, B. D. RATNER and T. A. HORBETT, J. Biomater. Sci., Polym. Ed. 12 (2001) 961.
L. TANG and J. W. EATON, J. Exp. Med. 178 (1996) 2147.
W. G. BRODBECK, E. COLTON and J. M. ANDERSON, J. Mater. Sci.: Mater. In Med. 14 (2003) 671.
L. TANG, T. P. UGAROVA, E. F. PLOW and J. W. EATON, J. Clin. Invest. 97 (1996) 1329.
L. TANG and J. W. EATON, J. Exp. Med. 178 (1993) 2147.
D. C. ALTIERI, J. PLESCIA and E. F. PLOW, J. Biol. Chem. 268 (1993) 1847.
T. P. UGAROVA, D. A. SOLOVJOV, L. ZHANG, D. I. LOUKINOV, V. C. YEE, L. V. MEDVED and E. F. PLOW, J. Biol. Chem. 273 (1998) 22519.
W. J. HU, J. W. EATON, T. P. UGAROVA, and L. TANG, Blood 98 (2001) 1231.
D. C. ALTIERI, A. DUPERRAY, J. PLESCIA, G. B. THORNTON, and L. R. LANGUINO, J. Biol. Chem. 270 (1995) 696.
S. T. SMILEY, J. A. KING, and W. W. HANCOCK, J. Immunol. 167(2001) 2887.
T. BREVIG, B. HOLST, Z. ADEMOVIC, N. ROZLOSNIK, J. H. RØHRMANN, N. B. LARSEN, O. C. HANSEN and P. KINGSHOTT, Biomaterials 26 (2005) 3039.
Z. ADEMOVIC, J. WEI, B. WINTHER-JENSEN, X. HOU and P. KINGSHOTT, Plasma Processes and Polymers 2 (2005), 53.
P. KINGSHOTT, H. THIESSEN and H. J. GRIESSER, Biomaterials 23 (2002) 2043.
R. R. COBB and J. L. MOLONY, FEBS Lett. 394 (1996) 241.
P. KINGSHOTT, K.BREMMELL, Z. ADEMOVIC and H. J. GRIESSER, manuscript in preparation.
M. BALCELLS, D. KLEE, M. FABRY and H. HOECKER, J. Colloid Interf. Sci. 220 (1999) 198.
L. TANG, T. P. UGAROVA, E. F. PLOW and J. W. EATON, J. Clin. Invest. 97 (1996) 1329.
P. THOMSEN and C. GRETZER, Curr. Opin. Sol. State Mat. Sci. 5 (2001) 163.
Z. ADEMOVIC, R. KHAN, T.BREVIG, X. HOU and B. WINTER-JENSEN, 19th European Conference on Biomaterials ESB2005, Sorrento, Italy, 9–15th Sept. (2005).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ademovic, Z., Holst, B., Kahn, R.A. et al. The method of surface PEGylation influences leukocyte adhesion and activation. J Mater Sci: Mater Med 17, 203–211 (2006). https://doi.org/10.1007/s10856-006-7306-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10856-006-7306-2